Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, commonly known as Bidiphar, is a prominent player in the pharmaceutical and medical equipment industry, headquartered in Binh Dinh, Vietnam. Established in 1977, Bidiphar has consistently evolved, marking significant milestones in its journey towards becoming a trusted name in healthcare. The company focuses on the production and distribution of high-quality pharmaceuticals, medical devices, and healthcare products, catering to both domestic and international markets. Bidiphar's commitment to innovation and quality sets it apart, with a diverse portfolio that includes prescription medications, over-the-counter drugs, and advanced medical equipment. With a strong market position, Bidiphar has garnered recognition for its contributions to public health and has established a reputation for reliability and excellence in the industry.
How does Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, the company has not established any reduction targets or initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi). This lack of formal commitments suggests that Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical and medical equipment industry increasingly prioritises sustainability, it is essential for companies like Binh Dinh to consider setting measurable targets and engaging in climate initiatives to align with global efforts to reduce greenhouse gas emissions.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.